Other
dHACM
dHACM is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
A Single Center, Prospective, Case Series of the Treatment of Pressure Ulcers and Decubitus Ulcers.
NCT03529578
completednot_applicable
Case Series of Weekly Applications of dHACM in Treatment of Pressure Ulcers
NCT02861560
completednot_applicable
Amniotic Membrane in Decompressive Craniectomy to Reduce Scarring
NCT02033824
Clinical Trials (3)
Showing 3 of 3 trials
NCT03529578Not Applicable
A Single Center, Prospective, Case Series of the Treatment of Pressure Ulcers and Decubitus Ulcers.
NCT02861560Not Applicable
Case Series of Weekly Applications of dHACM in Treatment of Pressure Ulcers
NCT02033824Not Applicable
Amniotic Membrane in Decompressive Craniectomy to Reduce Scarring
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3